ADCY9基因中的rs2601796变异与严重的喘和较少的支气管扩展剂反应有关
Helena M P Teixeira1, Álvaro A Cruz2, Talita S Jesus1
1Instituto de Ciências da Saúde, Universidade Federal da Bahia, Bahia, Brazil.
Gene
|August 14, 2023
概括
ADCY9基因的遗传变异与喘严重程度和支气管扩展剂反应的减少有关. rs2601796变种可能会影响ADCY9基因表达,影响喘结果,并可能引导个性化喘管理.
科学领域:
- 遗传学 遗传学 是一个
- 呼吸系统医学 呼吸系统医学
- 分子生物学分子生物学
背景情况:
- 喘是一种复杂的呼吸系统疾病,受遗传和环境因素的影响.
- ADCY9基因编码了第9型腺酸环酶,这种酶对循环腺单酸盐 (cAMP) 生产至关重要,影响支气管扩张和免疫反应.
研究的目的:
- 研究ADCY9基因变异 (rs2601796和rs2532019) 与喘以及肺功能之间的关联.
- 探索这些变异对支气管扩展剂响应和ADCY9基因表达的影响.
主要方法:
- 一项涉及1052名受试者的研究.
- 对共变量调整后的物流回归分析.
- 根据FEV1变化对支气管扩展剂反应的评估.
- 使用GTEx门户网站进行基因表达的in silico分析.
主要成果:
- 在严重的喘病例中,rs2601796变异 (AA/AG基因型) 与喘严重程度和呼吸道阻塞有积极的关联.
- 患有严重喘和rs2601796 AA/AG基因型的个体表现出支气管扩展剂反应降低和肺和血液组织中ADCY9表达率降低.
- rs2532019变体 (TT/GT基因型) 降低了ADCY9表达,但与喘表型没有显著的关联.
结论:
- ADCY9 rs2601796 变异与更差的喘结果有关,包括减少支气管扩展器反应,可能是由于基因表达的改变.
- 这种遗传标记可能有助于未来的喘患者个性化管理.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
302
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
302
Asthma: Pathogenesis and Management
446
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
446
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K


